UAB launches second round of urgent, high-impact COVID-19 research

UAB launches second round of urgent, high-impact COVID-19 research
The pilot projects will yield payoffs down the road from the knowledge UAB researchers gain. Preliminary data from the pilots will form the basis for new grants and contracts, including pursuit of the $2 billion COVID-19 grant support being offered by the National Institutes of Health. (Jeff Hansen/UAB)

Urgent high-impact COVID-19 research at the University of Alabama at Birmingham is catching a second breath, thanks to the generosity of Alabama business donors and the clinical skills of researchers.

Ten pilot projects – funded by $402,000 in donations – began Aug. 1. The projects will last six months and were selected for their high probability of having an impact on the COVID-19 crisis within weeks or months. Competition for funding was open to the entire university, resulting in 76 applications.

This round of research follows 14 projects advertised to faculty of the UAB School of Medicine that were funded beginning May 1, after the Birmingham and Montgomery business communities raised $1.1 million in March and April. Part of that money is helping fund this second round.

Kent Kyser, associate vice president, UAB Office of Research (UAB)

The pilot projects will yield payoffs down the road from the knowledge UAB researchers gain. Preliminary data from the pilots will form the basis for new grants and contracts, including pursuit of the $2 billion COVID-19 grant being offered to researchers nationwide by the National Institutes of Health.

“The number of high-quality proposals we received made the decision on which ones we could fund very difficult,” said Kent Keyser, associate vice president in the Office of Research. “These projects, together with the 14 projects funded in May by the UAB School of Medicine, show once again that UAB is at the forefront in fighting COVID-19. We are grateful for the philanthropic support that made the program possible.”

The 10 projects have 27 principal investigators or co-investigators, and they represent a broad swath of the UAB School of Medicine, as well as an investigator from the UAB School of Public Health.

The School of Medicine departments represented by these investigators include:

  • The Department of Medicine and its divisions of Pulmonary, Allergy and Critical Care Medicine; Gerontology and Geriatric Medicine; Infectious Diseases; Gastroenterology; Preventive Medicine and General Internal Medicine.
  • The Department of Pediatrics and its divisions of Pediatric Rheumatology, and Pediatric Pulmonary and Sleep Medicine.
  • The departments of Anesthesiology and Perioperative Medicine; Radiology; Cell, Developmental and Integrative Biology; Microbiology and Pathology.

The interactions of investigators from all these backgrounds fulfill part of UAB’s strategic plan, Forging the Future, with the objective of enhancing UAB’s institutional culture of collaboration and innovation.

The titles of the funded grants show the diverse research at UAB:

  • Clonal diversity of human antibodies to SARS-CoV-2 S-protein.
  • Glucocorticoid treatment of COVID-19 cytokine storm syndrome.
  • Therapeutics targeting COVID-19 entry into pulmonary epithelial cells.
  • Immunotyping COVID-related acute respiratory distress syndrome.
  • Circulating microbiota and microbial endotoxin drive uncontrolled immune activation of blood monocytes in COVID-19.
  • Development of a tri-specific neutralizing antibody for the treatment of SARS-CoV-2 infection.
  • Individual- and area-level risk factors for COVID-19 disparities in the Deep South.
  • Exploratory study of the effect of tranexamic acid treatment on the progression of COVID-19 in outpatients.
  • Molecular mechanisms underlying the pathogenesis of acute respiratory distress syndrome in critically ill SARS-CoV-2-infected patients.
  • Neutrophils as a driving mechanism of acute respiratory distress syndrome and death in COVID-19 patients.

    Jessica Towns, executive director of Development, UAB School of Medicine (UAB)

“We are deeply grateful to our local and national philanthropic partners for quickly responding with critical support needed to accelerate UAB’s COVID-19 research efforts,” said Jessica Towns, UAB School of Medicine executive director of Development. “Through our recent Day of Caring and ongoing fundraising initiatives, we have seen tremendous generosity from the community. This support provides significant resources and encouragement to our scientists, faculty, staff and students during this challenging time.”

Although the first round of pilots was advertised to the School of Medicine, the projects included funding for Sue Feldman, R.N., in the UAB School of Health Professions, to ensure scalability of the UAB helpbeatcovid19.org website to broader communities, including translating the site into Spanish. Helpbeatcovid19.org is a geographical symptom tracker, driven by crowdsourced, consumer-generated data to monitor and visualize COVID-19 symptoms across the United States with a focus on hard-to-reach communities in Alabama. Helpbeatcovid19.org provides valuable research data for use by researchers across the UAB campus. It is the precursor to Healthcheck, which is part of the GuideSafe platform of tools being used for returning to campus operations.

This story oriiginally appeared on the University of Alabama at Birmingham’s UAB News website.

Related Stories